Recall report: Sandoz yanks 1 lot of enoxaparin after exposure to warm temperatures
Sandoz has issued a recall of one lot of its enoxaparin sodium injection, 40 mg/.4 mL single-dose syringes after exposure to high temperatures may have impacted product effectiveness.
The lot, dubbed SAB06761A, could be a risk for patients with health conditions the product is intended to treat, such as stroke or heart attack. The patients, who are already at risk for blood clots, blocked blood vessels or arteries and swelling close to the lungs, are being treated for the prevention of deep vein thrombosis, a condition that occurs when blood clots form in a deep vein, usually in the legs, after surgeries or as a complication from a heart attack.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
